Molecular and clinical features of inherited neuropathies due to PMP22 duplication
1Department of Medicine, University of Maiduguri Teaching Hospital, PMB 1414 Maiduguri, Borno State, Nigeria.
Abstract:
PMP22 is a transmembrane glycoprotein component of myelin, important for myelin functioning. Mutation of PMP22 gene which encodes for the production of PMP22 glycoprotein is associated with a variety of inherited neuropathies. This literature review sought to review the molecular mechanism and clinical features of inherited neuropathies caused by PMP22 duplication. PMP22 duplication causes CMT1A which accounts for more than half of all CMT cases and about 70% of CMT1 cases. It manifests with muscle weakness, depressed reflexes, impaired distal sensation, hand and foot deformities, slowing of NCV and onion bulbs. With no specific treatment available, it is managed conservatively. Future treatment may be based on the molecular genetics of the disease.
Insights
PMP22 gene duplication causes Charcot-Marie-Tooth disease type 1A (CMT1A), a common inherited neuropathy. Current management is conservative, but future treatments may target the molecular genetics of PMP22 duplication.
Area of Science:
- Neuroscience and Genetics
- Molecular Biology of Myelin
Background:
- The peripheral myelin protein 22 (PMP22) is crucial for myelin sheath integrity and function.
- Mutations in the PMP22 gene are linked to various inherited peripheral neuropathies.
- PMP22 duplication is the primary genetic cause of Charcot-Marie-Tooth disease type 1A (CMT1A).
Purpose of the Study:
- To review the molecular mechanisms underlying inherited neuropathies resulting from PMP22 duplication.
- To detail the clinical manifestations associated with PMP22 duplication-induced neuropathies.
- To explore potential future therapeutic strategies based on molecular genetics.
Main Methods:
- Literature review of scientific articles and case studies.
- Analysis of molecular mechanisms and genetic alterations of the PMP22 gene.
- Compilation of clinical features and diagnostic findings in affected individuals.
Main Results:
- PMP22 duplication is responsible for over 50% of all Charcot-Marie-Tooth disease (CMT) cases and approximately 70% of CMT type 1 cases.
- Clinical presentation includes muscle weakness, reduced reflexes, distal sensory impairment, and limb deformities.
- Nerve conduction velocity (NCV) studies show slowing, and characteristic 'onion bulb' formations are observed in nerve biopsies.
Conclusions:
- PMP22 duplication is a significant genetic cause of CMT1A, characterized by specific clinical and electrophysiological findings.
- Currently, treatment for PMP22 duplication neuropathies is primarily conservative and symptomatic.
- Advances in understanding the molecular genetics of PMP22 duplication offer promise for developing targeted future therapies.
More Related Videos
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Abnormal Proliferation
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
